European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient
Chinese Clinical Oncology · 2024
DOI: 10.21037/cco-23-100 ↗Kurz gefasst
Editorial in der Zeitschrift Chinese Clinical Oncology, 2024. Verfasst von Guillermo Suay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Biomarkers and Precision Medicine Unit, Health Research Institute Hospital La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precision Medicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, Biomarkers and Precision Medicine Unit, Health Research Institute Hospital La Fe, Valencia, Spain.
- Medical Oncology Department, University and Polytechnic La Fe Hospital, Valencia, Spain.
Zitieren
APA
Suay, G., Aparisi, F., & Juan-Vidal, O. (2024). European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient. Chinese Clinical Oncology. https://doi.org/10.21037/cco-23-100
Vancouver
Suay G, Aparisi F, Juan-Vidal O. European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient. Chinese Clinical Oncology. 2024. doi:10.21037/cco-23-100
BibTeX
@article{Suay2024,
author = {Suay, Guillermo and Aparisi, Francisco and Juan-Vidal, Oscar},
title = {European Society of Medical Oncology (ESMO) guidelines for oncogene-addicted metastatic non-small cell lung cancer (NSCLC): a personalized treatment for each patient},
journal = {Chinese Clinical Oncology},
year = {2024},
doi = {10.21037/cco-23-100}
}
EUVIMED